Other Events · Jun 29, 2026

Polyrizon receives IRB approval to proceed with Allergy Blocker clinical trial

PLRZPolyrizon Ltd.

On June 29, 2026, Polyrizon Ltd. announced it received Central Institutional Review Board (IRB) approval for its Allergy Blocker clinical trial. The company operates in the biotechnology industry and develops medical treatments.